Co-Expression of LASS2 and TGF-β1 Predicts Poor Prognosis in Hepatocellular Carcinoma

Scientific Reports - United Kingdom
doi 10.1038/srep32421
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Decreased DC‑SIGNR Expression in Hepatocellular Carcinoma Predicts Poor Patient Prognosis

Oncology Letters
Cancer ResearchOncology
2019English

Increased Programmed Death Ligand-1 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients

OncoTargets and Therapy
OncologyPharmacology
2016English

High Expression of Thymosin Beta 10 Predicts Poor Prognosis for Hepatocellular Carcinoma After Hepatectomy

World Journal of Surgical Oncology
SurgeryOncology
2014English

Downregulation of Serum Exosomal miR‐320d Predicts Poor Prognosis in Hepatocellular Carcinoma

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2020English

Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma

Frontiers in Immunology
AllergyImmunology
2019English

Co-Expression of CXCL8 and HIF-1α Is Associated With Metastasis and Poor Prognosis in Hepatocellular Carcinoma

Oncotarget
Oncology
2015English

CELSR3 mRNA Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2019English

The Upregulation of Trophinin-Associated Protein (TROAP) Predicts a Poor Prognosis in Hepatocellular Carcinoma

Journal of Cancer
Oncology
2019English

Over-Expression of Cathepsin B in Hepatocellular Carcinomas Predicts Poor Prognosis of HCC Patients

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy